简体中文English

RB1(13q14)/ATM(11q22) gene deletion probe reagent
Wholesale Price(RMB):

30006000330066003300660036007200

Product Code:R-0501097Ⅰ-01/R-0501097Ⅰ-02/R-0501097Ⅱ-01/R-0501097Ⅱ-02/R-0501097Ⅲ-01/R-0501097Ⅲ-02/R-0501097Ⅳ-01/R-0501097Ⅳ-02
Probe name:GSP RB1 / GSP ATM
Product Code:Type I (direct FISH method)/Type II (biotin-labeled indirect FISH method)/Type III (digoxigenin-labeled indirect FISH method)/Type IV (TSA-FISH method)
Registration Number:
Clinical Value

Chronic lymphocytic leukemia CLL

13q deletion (RB1 is located at this locus) is the most common chromosomal abnormality in CLL, which occurs in 40%-60% of CLLs. del(13q14) alone is often seen at Binet stage A and has a better prognosis or is similar to that of a patient with a normal karyotype; the median survival (MS) is 133 months, and treatment-free survival (TFS) is up to 92 months. If accompanied by other chromosomal abnormalities such as +12, 11q, the prognosis is usually poorer. the incidence of ATM deletion is 12%-20%, and some patients, even if they do not have ATM deletion at the time of the initial diagnosis, can develop ATM deletion with the progression of the disease, suggesting that the deletion of ATM is closely related to the progression of CLL.